Below are the earnings highlights for Amneal Pharmaceuticals, Inc. (AMRX):
Earnings: -$91.643 million in Q1 vs. -$6.943 million in the same period last year.
EPS: -$0.30 in Q1 vs. -$0.05 in the same period last year.
Excluding items, Amneal Pharmaceuticals, Inc. reported adjusted earnings of $44.480 million or $0.14 per share for the period.
Analysts projected $0.09 per share
Revenue: $659.191 million in Q1 vs. $557.540 million in the same period last year.
-Guidance:
Full year EPS guidance: $0.53 to $0.63
Full year revenue guidance: $2.55 to $2.65 Bln
For comments and feedback: editorial@rttnews.com